| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/01/2004 | EP1451329A2 Genetic vaccine against human immunodeficiency virus |
| 09/01/2004 | EP1451322A2 Il-21 antagonists |
| 09/01/2004 | EP1451308A2 Therapeutic use of aziridino compounds |
| 09/01/2004 | EP1451226A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 09/01/2004 | EP1451216A1 Immunointeractive molecules and uses thereof |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451203A1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof |
| 09/01/2004 | EP1451196A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/01/2004 | EP1451192A1 Novel crystalline compound |
| 09/01/2004 | EP1451191A1 Thioether substituted imidazoquinolines |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451180A1 Quinazoline compounds with therapeutic use |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451174A2 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450856A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 09/01/2004 | EP1450855A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 09/01/2004 | EP1450850A1 Method of administering a thymosin alpha 1 peptide |
| 09/01/2004 | EP1450847A2 Apo2 ligand/trail formulations |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450824A1 Pharmaceutical composition |
| 09/01/2004 | EP1450822A2 Polymeric thiol-linked prodrugs |
| 09/01/2004 | EP1450821A1 Immunostimulatory oligodeoxynucleotides |
| 09/01/2004 | EP1450819A1 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
| 09/01/2004 | EP1450808A1 Quinazoline derivatives for the treatment of t cell mediated diseases |
| 09/01/2004 | EP1450804A1 Pharmaceutical formulations comprising an immune response modifier |
| 09/01/2004 | EP1450797A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450796A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1242410B1 Novel compounds |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP1014787B1 Adjuvant for transcutaneous immunization |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0978277B1 4,5-dihydroxy-2-cyclopentene-1-one for the treatment of rheumatism, inflammation and autoimmune diseases |
| 09/01/2004 | EP0969867B1 Use of anti-il-12 antibodies in transplantation rejection |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525871A Nasal delivery devices |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525854A Remedies for allergic eye diseases |
| 09/01/2004 | CN1525849A Olopatadine formulations for topical administration |
| 09/01/2004 | CN1524850A Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524576A Composite thymus peptide with immunoregulation function |
| 09/01/2004 | CN1524558A Immunologic function booster for treating AIDS and SARS |
| 09/01/2004 | CN1524545A Health care diet therapy preparation of ultrafine broad spectrum immune olyrhachis ants and the preparation method thereof |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1524518A Use of 2-amino-2(2-(4-octyl phenyl)ethyl)-1,3-propylene glycol in the preparation of medicaments of preventing and curing immune liver injury |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783771 Biologically active substance eem-sb obtained by extracting hypsizygus marmoreus with water, a lower alcohol having 1-4 and treating the extract using a molecular sieve method |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/31/2004 | CA2319150C .alpha.-ketoamide inhibitors of 20s proteasome |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072091A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 08/26/2004 | WO2004072081A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 08/26/2004 | WO2004072080A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity |
| 08/26/2004 | WO2004072058A1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072047A1 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 08/26/2004 | WO2004072027A2 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 08/26/2004 | WO2004071529A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | WO2004071520A1 Bifidobacterium preparation for improving immune functions |
| 08/26/2004 | WO2004071507A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071435A2 Enhanced Bioavailability Using Laser Resonant Homogenization |
| 08/26/2004 | WO2004071418A2 Compounds for the treatment of systemic lupus erythematosus |
| 08/26/2004 | WO2004063336A3 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 08/26/2004 | WO2004039834A3 Recombinant protein variants |